SARS-CoV-2 thereby increases the risk of thrombotic microangiopathy by potentially two synergistic mechanisms: First, the ubiquitous endothelial damage induces an excessive release of VWF, exceeding the protease activity of physiological concentrations of ADAMTS13. Here, VWF is linked to Genetic thrombotic microangiopathy.